Working... Menu

RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT03791476
Recruitment Status : Recruiting
First Posted : January 1, 2019
Last Update Posted : March 12, 2019
Pharming Technologies B.V.
Information provided by (Responsible Party):
University of Wisconsin, Madison

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2020
  Estimated Study Completion Date : December 2020